InsiderDB
Sign inStart free trial
Committee overlap: HELP

Sen. Alan Armstrong sold Pfizer (PFE)

Sen. Alan Armstrong (R-OK) · $50K–$100K · traded Mar 24, 2026

Why this is a committee overlap

Armstrong is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Pfizer is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$50K–$100K
Owner
The member
Traded
Mar 24, 2026
Disclosed
Jul 21, 2026
Days to disclose
119 (after the 45-day deadline)
Asset type
Stock
As filed
Pfizer, Inc. Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Armstrong's tradesAll Congress trades in PFE

Other trades in this filing

All of Armstrong's trades →

Recent Congress trades in PFE

Company context for PFE

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571868312!FENTANYL 100 MCG/2 ML VIAL 2ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 18, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571877159!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571877630!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.